Abstract
Get full access to this article
View all access options for this article.
References
1.Lysogene . Lysogene provides update on the AAVance clinical trial evaluating LYS-SAF302 in patients with MPS IIIA. https://www.lysogene.com/lysogene-provides-update-on-the-aavance-clinical-trial-evaluating-lys-saf302-in-patients-with-mps-iiia/ (last accessed
October 18 , 2020
).
2.Dyno Therapeutics. Dyno therapeutics enters collaboration and license agreement with roche to develop next-generation AAV gene therapy vectors for CNS diseases and liver-directed therapies . https://www.dynotx.com/news/press-releases/dyno-therapeutics-enters-collaboration-and-license-agreement-with-roche-to-develop-next-generation-aav-gene-therapy-vectors-for-cns-diseases-and-liver-directed-therapies/ (last accessed
October 17 , 2020
).
3.Voyager Therapeutics. Voyager therapeutics provides regulatory update on VY-HTT01 program . https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-provides-regulatory-update-vy-htt01-program (last accessed
October 18 , 2020
).
4.
Gardner
J
. FDA puts Voyager study on hold in latest gene therapy speed bump . BioPharma Dive. https://www.biopharmadive.com/news/voyager-huntington-gene-therapy-clinical-hold/586920/ (last accessed
October 18 , 2020
).
5.Solid Biosciences. Solid Biosciences announces FDA lifts clinical hold on IGNITE DMD clinical trial . https://www.solidbio.com/about/media/press-releases/solid-biosciences-announces-fda-lifts-clinical-hold-on-ignite-dmd-clinical-trial (last accessed
October 18 , 2020
).
6.Biogen, Inc., (BIIB) Q3 2020 Earnings Call Transcript . The Motley Fool. https://www.fool.com/earnings/call-transcripts/2020/10/21/biogen-inc-biib-q3-2020-earnings-call-transcript/ (last accessed
October 23 , 2020
).
7.U.S. Securities and Exchange Commission . Biogen Inc., Form 10-K Annual Report for the Fiscal Year Ended December 31, 2018. https://www.sec.gov/Archives/edgar/data/875045/000087504519000006/biib-20181231x10k.htm (last accessed
October 23 , 2020
).
8.Ori Biotech. Ori Biotech raises $30 million in series a financing to advance innovation in cell and gene therapy manufacturing . https://oribiotech.com/news/ori-biotech-raises-30-million-in-series-a-financing-to-advance-innovation-in-cell-and-gene-therapy-manufacturing (last accessed
October 17 , 2020
).